Please login to the form below

Not currently logged in
Email:
Password:

ODD

This page shows the latest ODD news and features for those working in and with pharma, biotech and healthcare.

FDA grants orphan drug status to Allogene’s BCMA-targeted treatment for multiple myeloma

FDA grants orphan drug status to Allogene’s BCMA-targeted treatment for multiple myeloma

The US Food and Drug Administration (FDA) has granted orphan-drug designation (ODD) to Allogene Therapeutics’ ALLO-715. ... We are pleased to have received ODD for ALLO-715 just months after the FDA granted RMAT designation.

Latest news

More from news
Approximately 1 fully matching, plus 101 partially matching documents found.

Latest Intelligence

More from intelligence
Approximately 0 fully matching, plus 26 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 0 fully matching, plus 18 partially matching documents found.

Subscribe to our email news alerts

Featured jobs

PMHub

Add my company
Aptus Health

Aptus Health is dedicated to advancing health engagement. The company offers end-to-end digital health engagement solutions spanning all areas of...

Latest intelligence

Our Top 5 Pharma Picks From Cannes Lions
Here are five of Art's top five pharma and healthcare picks from Cannes Lions 2022....
The Evolving Role of the Sales Rep
The COVID-19 pandemic sparked an evolution in physician engagement. Jill Padgett, EdD, Head of Training, explores what this means for the sales force and shares her advice for succeeding in...
Measure your omnichannel maturity with our new tool
Try our Omnichannel Maturity Tool to gain tangible advice and an instant analysis of your omnichannel readiness....